Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Design issues for drug epidemiology.

A D McMahon1, T M MacDonald

  • 1Robertson Centre for Biostatistics, University of Glasgow, Glasgow G12 8QQ, Scotland.

British Journal of Clinical Pharmacology
|November 9, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing the risk of endogeneity bias in health and mortality inequalities research using composite measures of multiple deprivation which include health-related indicators: A case study using the Scottish Index of Multiple Deprivation and population health and mortality data.

Health & place·2023
Same author

Economic Evaluation of the Protecting Teeth @ 3 Randomized Controlled Trial.

JDR clinical and translational research·2022
Same author

Cerebral-placental-uterine ratio as novel predictor of late fetal growth restriction: prospective cohort study.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2018
Same author

Is detecting oral cancer in general dental practices a realistic expectation? A population-based study using population linked data in Scotland.

British dental journal·2018
Same author

In response to: 'Thyroid hormone replacement - a counterblast to guidelines'.

The journal of the Royal College of Physicians of Edinburgh·2018
Same author

Presenting symptoms and long-term survival in head and neck cancer.

Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·2017
Same journal

N-acetylcysteine for non-paracetamol-induced acute liver failure in children: A systematic review and meta-analysis.

British journal of clinical pharmacology·2026
Same journal

Anti-seizure medications and DRESS in paediatric patients: A FAERS disproportionality and time-to-onset analysis.

British journal of clinical pharmacology·2026
Same journal

Modelling immune gene expression profiles as pharmacodynamic endpoints of antileishmanial treatment.

British journal of clinical pharmacology·2026
Same journal

The effect of mild and moderate hepatic impairment on the pharmacokinetics, safety and tolerability of balcinrenone.

British journal of clinical pharmacology·2026
Same journal

Relationship between continuous infusion meropenem PK/PD target attainment and C-reactive protein dynamics in onco-haematologic patients with febrile neutropenia.

British journal of clinical pharmacology·2026
Same journal

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx).

British journal of clinical pharmacology·2026
See all related articles

Drug epidemiology studies are crucial for identifying unexpected drug side effects, offering unique insights where randomized controlled trials (RCTs) are not feasible. This research explores essential study design elements and contrasts them with RCTs.

Area of Science:

  • Pharmacovigilance
  • Epidemiology
  • Clinical Research Design

Background:

  • Drug epidemiology studies are vital for detecting unforeseen adverse drug reactions.
  • Designing these studies presents unique challenges not always covered in standard literature.
  • Randomized controlled trials (RCTs) have limitations in certain drug safety investigations.

Purpose of the Study:

  • To discuss critical aspects of drug epidemiology study design.
  • To compare and contrast drug epidemiology with RCT methodologies.
  • To highlight situations where drug epidemiology is essential and RCTs are not suitable.

Main Methods:

  • Defining the study base and assembling a cohort.
  • Sampling referent controls from the study base or creating a secondary base.

Related Experiment Videos

  • Prioritizing new drug users and differentiating between acute and chronic use.

    • Main Results:

    • Drug epidemiology is most effective for studying unintended drug effects.
    • Confounding by indication often hinders efficacy studies, though exceptions exist.
    • Generalizability requires careful design considerations.

    Conclusions:

    • Drug epidemiology offers a valuable alternative and complement to RCTs for drug safety research.
    • Careful methodological choices, including cohort definition and user status, are key to valid drug epidemiology studies.
    • Understanding the shared and distinct design features between drug epidemiology and RCTs is crucial for effective research.